What’s at stake in the face the enforcement deadlines and how exception management lays the groundwork for future-ready ...

Antibiotics, antidepressants and other drugs frequently leach into the environment, where they can impact ecosystems and ...

as they must meet strict requirements around data handling, security, and compliance. Some critical factors influencing the adoption of generative AI in the pharmaceutical industry include ...

Healthcare professional (HCP) engagement is a term known to everyone who’s trying to win attention in the domain of pharma. Traditional ways to engage HCPs are losing their value, but new ...

In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

And these issues is creating costs, increased costs, both on the crew side, on the handling side ... which has a negative deviation versus the yield impact of that is NOK458 million.

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to pharmaceutical quality standards. Held in Hotel Westin Mumbai Garden City, ...

On Sunday, Trump took aim at the industry again, writing that the “Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs ...

During a briefing, a White House official pointed to tactics the pharmaceutical industry uses to prevent competition, such as deals with generic companies to delay market entry of cheaper ...

Trade groups representing biotech and pharmaceutical decried the move ... sessions on anticompetitive practices in the drug industry. On Monday, he was expected to ask the FTC to consider ...